Phibro Animal Health | PAHC - Current Liabilities


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Phibro Animal Health

Phibro Animal Health reported $165.31M in Current Liabilities for its fiscal quarter ending in March of 2023.


Current Liabilities Change
Align Technology ALGN:US USD 2B 78.71M
ANI Pharmaceuticals ANIP:US USD 125.82M 26.39M
Corcept Therapeutics CORT:US USD 78.86M 6.37M
Depomed DEPO:US USD 94.54M 771K
Eli Lilly LLY:US USD 16.01B 1.13B
Endo International ENDP:US USD 606.64M 82.98M
Henry Schein HSIC:US USD 2.17B 52M
Idexx Laboratories IDXX:US USD 1.07B 170.17M
Knight Therapeutics Inc GUD:CN CAD 135.45M 5.87M
Nektar Therapeutics NKTR:US USD 59.88M 8.32M
Pacira PCRX:US USD 98.7M 49.08M
Patterson Companies PDCO:US USD 1.17B 29.88M
Phibro Animal Health PAHC:US USD 165.31M 2.26M
Prestige Brands PBH:US USD 160.72M 539K
Supernus Pharmaceuticals SUPN:US USD 731.54M 43.59M
Zoetis ZTS:US USD 1.92B 1.25B